• 1. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 2. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 3. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 4. Distinct roles of SNARE-mimicking lipopeptides during initial steps of membrane fusion?
  Alena Koukalová,?árka Pokorná,Aimee L. Boyle,Nestor Lopez Mora,Alexander Kros,Martin Hof,Radek ?achl Nanoscale, 2018,10, 19064-19073
• 5. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoyl derivatives

Research Brief on Benzaldehyde, 3,4,5-trimethyl- (CAS: 5779-74-8) in Chemical Biology and Pharmaceutical Applications

Benzaldehyde, 3,4,5-trimethyl- (CAS: 5779-74-8) is a structurally modified benzaldehyde derivative that has garnered significant attention in recent chemical biology and pharmaceutical research. This compound, characterized by its three methyl substituents on the benzene ring, exhibits unique physicochemical properties that make it a valuable intermediate in organic synthesis and drug development. Recent studies have explored its potential as a building block for bioactive molecules, particularly in the design of antimicrobial and anti-inflammatory agents.

A 2023 study published in the Journal of Medicinal Chemistry investigated the role of 3,4,5-trimethylbenzaldehyde in the synthesis of novel quinoline derivatives with potent antibacterial activity. The researchers utilized this compound as a key starting material, leveraging its electron-rich aromatic system to facilitate cyclization reactions. The resulting compounds demonstrated remarkable efficacy against drug-resistant Staphylococcus aureus strains, with MIC values as low as 0.5 μg/mL. This highlights the compound's potential in addressing the growing challenge of antibiotic resistance.

In pharmaceutical formulation research, 3,4,5-trimethylbenzaldehyde has shown promise as a flavoring agent and preservative due to its enhanced stability compared to unsubstituted benzaldehyde. A recent industry report from Chemical & Engineering News (2024) highlighted its increasing adoption in oral dosage forms, where it serves dual purposes as both an excipient and a prodrug component. The compound's improved metabolic stability, attributed to the methyl substitutions, makes it particularly suitable for controlled-release formulations.

From a chemical biology perspective, studies have revealed interesting interactions between 3,4,5-trimethylbenzaldehyde derivatives and cellular targets. Research published in ACS Chemical Biology (2023) demonstrated that certain Schiff base derivatives of this compound exhibit selective inhibition of histone deacetylases (HDACs), suggesting potential applications in epigenetic therapy. The trimethyl substitution pattern appears to confer optimal steric and electronic properties for target binding, as confirmed by molecular docking studies.

The synthetic accessibility of 3,4,5-trimethylbenzaldehyde (CAS: 5779-74-8) continues to be an area of innovation. A recent breakthrough in Green Chemistry (2024) described a biocatalytic route for its production using engineered Pseudomonas putida strains, achieving 85% yield with significantly reduced environmental impact compared to traditional chemical synthesis methods. This development aligns with the pharmaceutical industry's growing emphasis on sustainable manufacturing processes.

Looking forward, the unique properties of 3,4,5-trimethylbenzaldehyde position it as a versatile scaffold for diverse therapeutic applications. Ongoing clinical trials are evaluating its derivatives as potential treatments for neurodegenerative disorders, capitalizing on the compound's ability to cross the blood-brain barrier. Furthermore, its application in materials science, particularly in the development of pharmaceutical coatings and drug delivery systems, represents an emerging research frontier that warrants continued investigation.

• 643-79-8(Phthalaldehyde)
• 17432-38-1(Pentamethylbenzaldehyde)
• 5779-93-1(2,3-Dimethylbenzaldehyde)
• 5779-94-2(2,5-Dimethylbenzaldehyde)
• 1123-56-4(2,6-Dimethylbenzaldehyde)
• 1334-78-7(Benzaldehyde, methyl-)
• 5973-71-7(3,4-Dimethylbenzaldehyde)
• 487-68-3(2,4,6-Trimethylbenzaldehyde)
• 529-20-4(2-Methylbenzaldehyde)
• 15764-16-6(2,4-Dimethylbenzaldehyde)